In clinical hypertrophic cardiomyopathy patients, inclusion of the papillary muscles in cardiac magnetic resonance image analysis resulted in a significant 8.7% relative increase in calculated left ventricular mass.
Cross-Sectional (n=69)
Does inclusion of papillary muscles in CMR analysis affect LV ejection fraction and mass in patients with hypertrophic cardiomyopathy?
Inclusion of papillary muscles in CMR analysis significantly increases calculated LV mass and ejection fraction in HCM patients, highlighting the need for standardized imaging protocols.
Estimación del efecto: 8.7% relative difference
Tasa de eventos absoluta: 85.2% vs 78.5%
valor p: p=<0.01
PURPOSE: The use of cardiac magnetic resonance (CMR) analysis has increased in patients with hypertrophic cardiomyopathy (HCM). Quantification of left ventricular (LV) measures will be affected by the inclusion or exclusion of the papillary muscles as part of the LV mass, but the magnitude of effect and potential consequences are unknown. METHODS: We performed Cine-CMR in (1) clinical HCM patients (n = 55) and (2) subclinical HCM mutation carriers without hypertrophy (n = 14). Absolute and relative differences in LV ejection fraction (EF) and mass were assessed between algorithms with and without inclusion of the papillary muscles. RESULTS: Papillary muscle mass in group 1 was 6.6 ± 2.5 g/m(2) and inclusion of the papillary muscles resulted in significant relative increases in LVEF of 4.5 ± 1.8 % and in LV mass of 8.7 ± 2.6 %. For group 2 these figures were 4.0 ± 0.9 g/m(2), 3.8 ± 1.0 % and 9.5 ± 1.8 %, respectively. With a coefficient of variation of 4 %, this 9 % difference in LV mass during CMR follow-up will be considered a change, while in fact the exact same mass may have been assessed according to two different algorithms. CONCLUSIONS: In clinical HCM patients, CMR quantification of important LV measures is significantly affected by inclusion or exclusion of the papillary muscles. In relative terms, the difference was similar in subjects without hypertrophy. This underscores a general need for a uniform approach in CMR image analysis.
Gommans et al. (Thu,) conducted a cross-sectional in Hypertrophic cardiomyopathy (n=69). CMR image analysis with inclusion of papillary muscles in LV mass vs. CMR image analysis with exclusion of papillary muscles from LV mass was evaluated on Left ventricular mass (g/m2) in clinical HCM patients (8.7% relative difference, p=<0.01). In clinical hypertrophic cardiomyopathy patients, inclusion of the papillary muscles in cardiac magnetic resonance image analysis resulted in a significant 8.7% relative increase in calculated left ventricular mass.